Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
51.47
-0.26 (-0.50%)
At close: Aug 28, 2026, 4:00 PM EDT
52.49
+1.02 (1.98%)
After-hours: Aug 28, 2026, 7:35 PM EDT

Axogen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
251.17225.21187.34159.01138.58127.36
Revenue Growth
23.57%20.21%17.81%14.74%8.82%13.41%
Cost of Revenue
63.9157.8645.3637.1429.7822.93
Gross Profit
187.27167.35141.98121.87108.81104.43
Selling, General & Admin
164.07142.32117.5115.99112.89105.67
Research & Development
36.0532.8927.7727.3425.6324.18
Operating Expenses
200.11175.2145.26143.33138.52129.84
Operating Income
-12.85-7.85-3.29-21.46-29.71-25.42
Interest Expense
-4.17-7.7-8.21-2.84-0.62-1.36
Interest & Investment Income
2.231.171.141.490.570.09
Other Non Operating Income (Expenses)
-1.91-1.320.391.090.81-0.31
EBT Excluding Unusual Items
-16.7-15.7-9.96-21.72-28.95-26.99
Other Unusual Items
-16.85-----
Pretax Income
-33.55-15.7-9.96-21.72-28.95-26.99
Net Income
-33.55-15.7-9.96-21.72-28.95-26.99
Net Income to Common
-33.55-15.7-9.96-21.72-28.95-26.99
Net Income Growth
------
Shares Outstanding (Basic)
504644434241
Shares Outstanding (Diluted)
504644434241
Shares Change
9.28%4.05%3.22%1.89%2.11%3.12%
EPS (Basic)
-0.68-0.34-0.23-0.51-0.69-0.65
EPS (Diluted)
-0.68-0.34-0.23-0.51-0.69-0.65
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
8.6-2.931.43-19.59-36.14-41.22
Free Cash Flow Per Share
0.17-0.060.03-0.46-0.86-1.00
Gross Margin
74.56%74.31%75.79%76.64%78.52%81.99%
Operating Margin
-5.12%-3.48%-1.75%-13.50%-21.44%-19.96%
Profit Margin
-13.36%-6.97%-5.32%-13.66%-20.89%-21.19%
Free Cash Flow Margin
3.42%-1.30%0.77%-12.32%-26.08%-32.36%
EBITDA
-5.97-0.873.45-16.97-26.62-22.47
EBITDA Margin
-2.38%-0.39%1.84%-10.67%-19.20%-17.64%
D&A For EBITDA
6.886.986.734.493.092.95
EBIT
-12.85-7.85-3.29-21.46-29.71-25.42
EBIT Margin
-5.12%-3.48%-1.75%-13.50%-21.44%-19.96%
SEC Filings: 10-K · 10-Q